Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years
Clinical trial NCT01191060 · COMPLETED
Trial details
- NCT number
- NCT01191060
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2018-11-30
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.